Ipamorelin / CJC-1295 No DAC 10mg Research Blend
This vial contains a research-grade blend of Ipamorelin and CJC-1295 Without DAC (also known as Modified GRF 1-29), two complementary growth hormone secretagogues that act synergistically through different but compatible mechanisms. Ipamorelin is a selective GHRP (growth hormone releasing peptide) that acts on the ghrelin receptor, while CJC-1295 No DAC is a GHRH analogue that acts on the GHRH receptor. Their combined use in research models is designed to stimulate GH secretion via dual-pathway activation. This 10mg blend vial is HPLC and MS/MS verified at ≥99% purity.
Research Background
Ipamorelin is noted for its selectivity — it stimulates GH release with minimal effect on cortisol and prolactin compared to earlier GHRPs, making it a cleaner research tool for isolated GH secretion studies. CJC-1295 Without DAC has a shorter half-life than the DAC version, producing a more physiological GH pulse pattern. Researchers studying GH secretagogue combinations frequently use this pairing for its complementary receptor mechanisms and pulse-mimicking profile.
Compound Specifications
- Format: Lyophilized powder (combined blend)
- Purity: ≥99% per component (HPLC verified)
- Quantity: 10mg per vial
- Storage: −20°C, protected from light
- Components: Ipamorelin + CJC-1295 Without DAC (Modified GRF 1-29)
Certificate of Analysis
All blend vials are third-party tested by independent ISO-certified laboratories with HPLC and MS/MS validation of both components per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
